Following enhanced credit expiration, 80% of continuing Marketplace enrollees reported higher cost sharing year over year, and 51% said costs were “a lot higher.” Financial toxicity concerns were ...
All-urban residence correlated with longer treatment initiation times despite an a priori hypothesis favoring rural delays, suggesting urban-system bottlenecks rather than geographic distance alone.
Sanctions are a key tool that states use to hold Medicaid managed care organizations (MCOs) accountable for their use of public funds. The 2023 reports that MCOs submit ...
Linerixibat targets pruritus pathobiology in PBC by blocking ileal bile acid reuptake, aiming to lower circulating pruritogenic bile acid–related mediators. GLISTEN demonstrated greater 24-week WI-NRS ...
A >500-patient, randomized, double-blind phase 3 trial showed CT-P43 achieved PASI 75 equivalence at week 12 versus ustekinumab under standard induction and q12w maintenance dosing. Durability through ...
The newly approved mosunetuzumab for relapsed/refractory follicular lymphoma improves clinic efficiency and patient experience, says Zahra Mahmoudjafari, PharmD, MBA, BCOP. She also explained how the ...
In this episode, ‘Assessing Clinical and Economic Factors in Treatment Selection and Payer Decision-Making,’ the panelists ...
Fred D. Lublin, MD, discusses therapy sequencing, deescalation, health equity, and the future of multiple sclerosis (MS) care delivery. Effective multiple sclerosis (MS) treatment requires thinking ...
Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, ...
Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...
SEER-Medicare analyses across 2005–2007, 2010–2012, and 2017–2019 showed persistently lower adjusted curative-treatment rates for Black vs White beneficiaries with early-stage NSCLC (all P<.001).
Humorous tone undermined engagement, whereas factual, straightforward framing aligned better with expectations for high-stakes vaccine communication. Disease-specific content performed best, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results